Medical Properties Trust, Inc. (NYSE:MPW) to Issue Quarterly Dividend of $0.08

Key Points

• Medical Properties Trust, Inc. has announced a quarterly dividend of $0.08 per share, payable on October 9th to investors of record on September 11th, yielding an annualized rate of 7.7%.
• The company has a concerning payout ratio of 188.2%, indicating it cannot fully cover its dividend with earnings alone, relying instead on its balance sheet.
• Despite a recent stock price uptick of 0.6% to $4.16, Medical Properties Trust reported a quarterly earnings miss with negative net margins and revenue down by 9.8% year-over-year.

Medical Properties Trust, Inc. (NYSE:MPW - Get Free Report) declared a quarterly dividend on Thursday, August 14th, RTT News reports. Investors of record on Thursday, September 11th will be given a dividend of 0.08 per share by the real estate investment trust on Thursday, October 9th. This represents a c) dividend on an annualized basis and a yield of 7.7%.

Medical Properties Trust has a payout ratio of 188.2% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect Medical Properties Trust to earn $0.62 per share next year, which means the company should continue to be able to cover its $0.32 annual dividend with an expected future payout ratio of 51.6%.

Medical Properties Trust Stock Up 0.6%

Medical Properties Trust stock traded up $0.03 during mid-day trading on Thursday, reaching $4.16. The company's stock had a trading volume of 8,112,261 shares, compared to its average volume of 10,566,165. The company has a market capitalization of $2.50 billion, a price-to-earnings ratio of -1.74 and a beta of 1.28. Medical Properties Trust has a 12 month low of $3.51 and a 12 month high of $6.55. The business's 50 day simple moving average is $4.28 and its 200 day simple moving average is $4.90. The company has a debt-to-equity ratio of 2.00, a quick ratio of 3.23 and a current ratio of 2.76.

Medical Properties Trust (NYSE:MPW - Get Free Report) last released its earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). The business had revenue of $240.36 million during the quarter, compared to the consensus estimate of $231.90 million. Medical Properties Trust had a negative net margin of 155.20% and a negative return on equity of 28.80%. The firm's revenue for the quarter was down 9.8% on a year-over-year basis. During the same period last year, the business posted $0.23 EPS. As a group, research analysts anticipate that Medical Properties Trust will post 0.78 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have commented on MPW shares. Wall Street Zen cut shares of Medical Properties Trust from a "hold" rating to a "sell" rating in a research note on Saturday, July 5th. Royal Bank Of Canada cut their price target on shares of Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating for the company in a research note on Monday, June 30th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $5.67.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.